Amy Valley, vice president for Clinical Strategy and Technology Solutions at Cardinal Health, discusses challenges presented within the oncology community, and how Cardinal Health is addressing these issues.
Cost management utilization tools can overcome access barriers to care within the oncology community that often falls short with the use of prior authorization, said Amy Valley, vice president for Clinical Strategy and Technology Solutions at Cardinal Health.
Transcript
What are you the most excited about or looking forward to this year at the 2023 Community Oncology Alliance Community Oncology Conference?
It's always exciting to reconnect with colleagues. I really enjoy just seeing all the people that I've known over the years in community oncology. I'm really excited this year that we are launching a new tool called Care Exchange, which will help practices have a better understanding of total cost of care, as they're navigating value-based reimbursement programs. So, very excited to be able to share that with the attendees.
You have identified many current challenges with prior authorization in oncology care. Are you hopeful that any of the recent attention from Congress on this issue will make a difference?
I am hopeful. I think the reality though will be that it will take time. I think, ultimately, we would like the prior authorization process to be dramatically changed in order to remove the barriers to getting patients on therapy in a timely fashion. But, I think those changes will be slow.
I think that payers will hang on to that as one of the few utilization management tools that they have that they feel comfortable with and they can operate. And it's hard to drive that change.
From my perspective, we're still avidly investing in tools to help alleviate the burden of prior authorization. And especially if you think about the practices, work, staff challenges that they have right now, that anything you can do to save time and to allow the staff to overcome these administrative burdens is of high value. Because of that, we're very interested in being able to make prior authorizations not so cumbersome for them to manage. Hopefully we save them time. And we can, again get patients on therapy in a more efficient manner.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More
2 Commerce Drive
Cranbury, NJ 08512